close
Add to watchlist
Conceptus Inc (CPTS) Healthcare, Medical Equipment & Supplies
Conceptus, Inc. designs, develops, and markets minimally invasive devices for reproductive medical applications in the United States. The company offers Essure, a permanent birth control system for women. The Essure system uses a micro-insert that is delivered into a woman's fallopian tubes to provide permanent birth control by causing a benign tissue in-growth that blocks the fallopian tubes. The company distributes its products through direct sales force and distributor networks, as well as media, including television, radio, direct mail, and print to gynecologists and general practitioners. Conceptus, Inc. was founded in 1992 and is headquartered in Mountain View, California.
(login to add this stock to your watchlist or favorites)
Key Statistics
| Closing Price | 14.29 |
| Volume | 72050 |
| Volume Avg | 190235 |
| 52 Week High | 15.70 |
| 52 Week Low | 9.68 |
| PE | N/A |
| PE (group average) | 39 |
| EPS Year | -0.25 |
| EPS change Q/Q | 1000% |
| EPS change Q/Q Yr ago | -12.5% |
| EPS change Q/Q next Q est | 100% |
| EPS change Y/Y | -88.17% |
| REV change Q/Q | -27.32% |
| REV change Q/Q Yr ago | -20.36% |
| EPS next Q est | 0.00 |
| EPS next Y est | 0.18 |
| Divident Annual | 0.00 |
| Dividend Yield | 0% |